About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Subjective Well Being of Schizophrenic Patients in Greece

NCT00857064·24 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Provision of written informed consent
Diagnosis of schizophrenia according to DSM-IV
The patient must have been prescribed an atypical antipsychotic for at least 4 weeks before the first study visit

You may not be if

\-

The record

StatusCompleted

PhaseNo phase

Taking part600

StartedMar 2009

UpdatedDec 9, 2010

Conditions

Where24

Research Site
Agrinio, Greece
Research Site
Alexsandroupoli, Greece
Research Site
Argos, Greece

Clareo Health | Subjective Well Being of Schizophrenic Patients in Greece